PIERIS PHARMACEUTICALS, INC. (PIRS) Return On Equity % [USD] 2015 - 2023

Historical data

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Pieris Pharmaceuticals, Inc. annual/quarterly Return On Equity history and growth rate from 2015 to 2023.
  • Pieris Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2014 was -2.07 M %.
  • Pieris Pharmaceuticals, Inc. annual Return On Equity for 2023 was -86.7 %, a 5.21% decline from 2022.
  • Pieris Pharmaceuticals, Inc. annual Return On Equity for 2022 was -82.4 %, a 14.6% increase from 2021.
  • Pieris Pharmaceuticals, Inc. annual Return On Equity for 2021 was -96.5 %, a 10.9% decline from 2020.
Return On Equity, Annual (% [USD])
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -86.7 -4.29 -5.21% Jan 1, 2023 Dec 31, 2023
2022 -82.4 +14.1 +14.6% Jan 1, 2022 Dec 31, 2022
2021 -96.5 -9.52 -10.9% Jan 1, 2021 Dec 31, 2021
2020 -87 -3.24 -3.87% Jan 1, 2020 Dec 31, 2020
2019 -83.8 -29.2 -53.6% Jan 1, 2019 Dec 31, 2019
2018 -54.5 +108 +66.4% Jan 1, 2018 Dec 31, 2018
2017 -162 -87.2 -116% Jan 1, 2017 Dec 31, 2017
2016 -75.3 -12.9 -20.6% Jan 1, 2016 Dec 31, 2016
2015 -62.4 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.